(ANSA) - BRUSSELS, MARCH 18 - "Many Member States are waiting for the result of this review on the safety" of the AstraZeneca vaccine, "have indicated that what the EMA does from a scientific point of view is very important for them to make a decision on how to continue with vaccinations.
Today we are keeping our promise. "
Thus the director of the European Medicines Agency (EMA), Emer Cooke, press conference.
"Our responsibility is to come to a conclusion about whether or not the benefits outweigh the risks so they can make an informed decision and build confidence in the vaccine," he added.
The AstraZeneca vaccine package insert "needs to be up-to-date: it is important that it be communicated to the public and healthcare professionals so that they learn this information better, allowing them to mitigate these side effects."
This was said by Sabien Straus, president of the Prac (Pharmacovigilance Commission), in the press conference of the EMA.
(HANDLE).
